Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype.
Epilepsy is a common disorder, typified by recurrent seizures with underlying neurological disorders or disease. Approximately one-third of patients are unresponsive to currently available therapies. Thus, a deeper understanding of the genetics and etiology of epilepsy is needed to advance the development of new therapies. Previously, treatment of zebrafish with epilepsy-inducing pharmacological agents was shown to result in a seizure-like phenotype, suggesting that fish provide a tractable model to understand the function of epilepsy-predisposing genes. Here, we report the first model of genetically linked epilepsy in zebrafish and provide an initial characterization of the behavioral and neurological phenotypes associated with morpholino (MO) knockdown of leucine-rich, glioma-inactivated 1a (lgi1a) expression. Mutations in the LGI1 gene in humans have been shown to predispose to a subtype of autosomal dominant epilepsy. Low-dose Lgi1a MO knockdown fish (morphants) appear morphologically normal but are sensitized to epilepsy-inducing drugs. High-dose Lgi1a morphants have morphological defects which persist into adult stages that are typified by smaller brains and eyes and abnormalities in tail shape, and display hyperactive swimming behaviors. Increased apoptosis was observed throughout the central nervous system of high-dose morphant fish, accounting for the size reduction of neural tissues. These observations demonstrate that zebrafish can be exploited to dissect the embryonic function(s) of genes known to predispose to seizure-like behavior in humans, and offer potential insight into the relationship between developmental neurobiological abnormalities and seizure.
Teng
Yong
Y
MCG Cancer Center, Medical College of Georgia, School of Medicine, 1120 15th Street, Augusta, GA 30912, USA.
Xie
Xiayang
X
Walker
Steven
S
Rempala
Grzegorz
G
Kozlowski
David J
DJ
Mumm
Jeff S
JS
Cowell
John K
JK
D000818:Animals; D001921:Brain / Q000002:abnormalities* / Q000378:metabolism; D004625:Embryo, Nonmammalian / Q000378:metabolism; D005123:Eye / Q000196:embryology / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D055785:Gene Knockdown Techniques; D009419:Nerve Tissue Proteins / Q000235:genetics*; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D010641:Phenotype; D012640:Seizures / Q000235:genetics* / Q000378:metabolism; D015027:Zebrafish / Q000002:abnormalities / Q000235:genetics* / Q000254:growth & development; D029961:Zebrafish Proteins / Q000235:genetics*
C555909:Lgi1a protein, zebrafish; D009419:Nerve Tissue Proteins; D016376:Oligonucleotides, Antisense; D029961:Zebrafish Proteins
Epilepsia. 2007 Jun;48(6):1151-7
17521353
Mol Biol Evol. 2005 Nov;22(11):2209-16
16014869
Oncogene. 1998 Dec 3;17(22):2873-81
9879993
MMWR Surveill Summ. 2008 Aug 8;57(6):1-20
18685554
Mamm Genome. 2007 May;18(5):328-37
17565425
Nat Genet. 2002 Mar;30(3):335-41
11810107
Annu Rev Neurosci. 2003;26:599-625
14527270
Hum Mol Genet. 2006 Dec 1;15(23):3436-45
17067999
Epilepsia. 2005;46 Suppl 10:59-60
16359474
Genomics. 2010 Feb;95(2):93-100
19835947
Hum Mol Genet. 2010 May 1;19(9):1702-11
20130004
J Pharmacol Toxicol Methods. 2008 May-Jun;57(3):176-87
18337127
Science. 2006 Sep 22;313(5794):1792-5
16990550
Neurology. 2007 Sep 18;69(12):1298-300
17875918
Hum Mutat. 2009 Apr;30(4):530-6
19191227
Neuron. 2006 Mar 2;49(5):697-706
16504945
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3799-804
20133599
Ann Neurol. 1999 Feb;45(2):182-8
9989620
Hum Mol Genet. 2005 Jun 15;14(12):1613-20
15857855
Nat Med. 2009 Oct;15(10):1208-14
19701204
Exp Neurol. 2008 Jun;211(2):480-8
18402939
Development. 2008 May;135(10):1735-43
18403413
Nat Rev Genet. 2007 May;8(5):353-67
17440532
Nat Genet. 1995 May;10(1):56-60
7647791
Dev Dyn. 1995 Jul;203(3):253-310
8589427
Hum Mol Genet. 2009 Apr 15;18(R1):R107-12
19297397
Am J Med Genet. 2001 Summer;106(2):146-59
11579435
Arch Neurol. 2003 Nov;60(11):1546-51
14623726
Biochem Biophys Res Commun. 2007 Jun 29;358(2):521-7
17493584
Neuroscience. 2005;131(3):759-68
15730879
Epilepsia. 2003 Oct;44(10):1289-97
14510822
Epilepsy Res. 2007 Jun;75(1):18-28
17485198
Curr Opin Neurol. 2004 Apr;17(2):147-53
15021241